FindTrial
Sign In

Screening and validation of potential susceptibility loci of pancreatic cancer and genetic risk score in pancreatic cancer diagnosis

Susceptibility loci and genetic risk score for diagnosis of pancreatic cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-14005393
Enrollment
Unknown
Registered
2014-09-04
Start date
2014-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Cases group :NA
Control group :NA

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Cases included in the study should between 18 to 90 years old; 2. Pathological diagnosis of surgical patients should be pancreatic ductal adenocarcinoma; 3. CT scan showed pancreatic full nodules, histologically or cytologically confirmed primary tumor tissue from tumor tissue or liver metastasis of primary pancreatic cancer (pancreatic ductal adenocarcinoma) in non-surgical patients.

Exclusion criteria

Exclusion criteria: 1. Patients with metastatic pancreatic tumors or have a history of any other cancers; 2. Patients refuse to participate in the research or telephone follow-up.

Design outcomes

Primary

MeasureTime frame
Specific locus genotype;serum CA19-9 level;—

Countries

Shanghai

Contacts

Public ContactWang Xiaolin
wang.xiaolin@zs-hospital.sh.cn+86 13916047618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026